Speakers

Jeffrey Berns, John Glaspy, David Henry, Ajay Singh, Wendy St. Peter

Jeffrey Berns, MD

Associate Chief of the Renal, Electrolyte, and Hypertension Division
Professor of Medicine and Pediatrics
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Dr. Jeffrey Berns is Professor of Medicine and Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. After 12 years in private practice, Dr. Berns joined the faculty of the University of Pennsylvania, where he is Associate Chief of the Renal, Electrolyte, and Hypertension Division, Director of the Nephrology Fellowship Training Program, and Associate Dean for Graduate Medical Education.

Dr. Berns is co-deputy editor of the American Journal of Kidney Diseases (AJKD) and Nephrology Editor-in-Chief and Dialysis Section co-editor for UpToDate. He is Chair of the American Board of Internal Medicine (ABIM) Nephrology Subspecialty Board. He is immediate Past-President of the National Kidney Foundation.

Dr. Berns has authored over 200 articles and book chapters. He has been actively involved in medical education throughout his career and is the recipient of numerous teaching awards from the University of Pennsylvania. Dr. Berns maintains a general nephrology practice at the Hospital of the University of Pennsylvania.

Back to top

John Glaspy, MD, MPH

Estelle, Abe, and Marjorie Sanders Endowed Chair in Cancer Research
Jonsson Comprehensive Cancer Center
Professor of Medicine
University of California, Los Angeles (UCLA) David Geffen School of Medicine
Los Angeles, California

John Glaspy, MD, MPH, is Professor of Medicine at the Jonsson Comprehensive Cancer Center (JCCC) of the University of California, Los Angeles (UCLA) School of Medicine in Los Angeles, California. Dr. Glaspy holds the Estelle, Abe, and Marjorie Sanders Endowed Chair in Cancer Research. He is Director of the JCCC Clinical Research Unit and Director of the JCCC Women’s Cancer Research Program.

Dr. Glaspy is a member of the American Society of Clinical Oncology, Southwest Oncology Group, American Federation for Clinical Research, International Society of Interferon Research, and American Society of Nuclear Medicine, among others. He is also a Fellow of the American College of Physicians. During the course of his career, Dr. Glaspy has authored more than 280 articles, abstracts, and book chapters. He has received numerous awards and honors, including being named one of the “Best Doctors in America.” Dr. Glaspy serves as the Chair of the Management Committee and was involved in the design and founding of Stand Up to Cancer, an organization that has Dr. Glaspy serves as the Chair of the Management Committee and was involved in the design and founding of Stand Up to Cancer, an organization that has raised 120 million dollars for cancer research to date.

Currently, Dr. Glaspy is involved in basic research in tumor immunology and the effects of fatty acids on carcinogenesis. His clinical interests also include chemotherapy-induced anemia, the role of hematopoietic growth factors in cancer management, and improvement in stem cell harvest for bone marrow transplantation, new approaches to the treatment of breast cancer and malignant melanoma.

Dr. Glaspy received his MD from the UCLA School of Medicine and his MPH in Health Services Administration from the UCLA School of Public Health. He completed his residency in Internal Medicine and his fellowship in Hematology and Oncology at the UCLA School of Medicine.

Back to top

David Henry, MD

Clinical Professor of Medicine
University of Pennsylvania School of Medicine
Vice Chairman, Department of Medicine
Division of Hematology/Oncology
Pennsylvania Hospital
Philadelphia, Pennsylvania

Dr. Henry is Clinical Professor of Medicine at the University of Pennsylvania School of Medicine in Philadelphia. He is a member of the medical staff at Pennsylvania Hospital in the Division of Hematology/Oncology and Vice Chairman of the Department of Medicine.

Dr. Henry received his Medical Degree at the University of Pennsylvania School of Medicine. His postgraduate training included an internship and residency in medicine and a fellowship in Hematology/Oncology at the Hospital of the University of Pennsylvania, where he also served as chief medical resident. Dr. Henry is board certified in internal medicine and holds subspecialty certification in both hematology and oncology. He is Editor of the Journal of Community and Supportive Oncology.

Dr. Henry is a member of several professional organizations including the American Society of Hematology and American Society of Clinical Oncology. He is a reviewer for Annals of Internal Medicine and the Journal of Clinical Oncology. His area of research is HIV malignancies, anemia and hematologic growth factors including GCSF and EPO/ESA’s, and IV iron. He is also one of the National Anemia Consultants for the American Society of Hematology.

Back to top

Ajay Singh, MBBS, FRCP, MBA

Senior Associate Dean for Global and Continuing Education
Director, Master in Medical Sciences in Clinical Investigation Program
Harvard Medical School
Boston, Massachusetts

Dr. Singh is Senior Associate Dean for Post Graduate Medical Education at Harvard Medical School (HMS) and Director of the Master in Medical Sciences in Clinical Investigation (MMSCI) Program. He leads a vibrant group of faculty and staff in developing and overseeing postgraduate medical education at HMS, as well as the Master's program in Clinical Investigation. He has been Executive Director for the Dubai Harvard Foundation of Medical Research since 2008.

Dr. Singh completed his undergraduate and medical training in England at University College London School of Medicine. He moved to Boston in 1987 for his clinical and research renal fellowship at Tufts-New England Medical Center, which he finished in 1992, when he joined the Tufts University faculty. In 1998 he moved to the Brigham and Women’s Hospital — one of the principal teaching hospitals of Harvard Medical School — as Clinical Director of the Renal Division and Director of Dialysis Services and Associate Professor of Medicine at HMS.

Dr. Singh’s interests are in clinical research with a particular focus on the anemia of chronic kidney disease. He has led groundbreaking studies in anemia of kidney disease, including the CHOIR study, which was published in the New England Journal of Medicine, and well as being a member of the steering committees for the TREAT and DRIVE studies. More recently, he has taken on the role of leading the ASCEND Clinical development program — a phase 3 program for the development of a novel prolyl hydroxylase inhibitor daprodustat. The trial is aiming to recruit 7500 patients in several countries.

Dr. Singh currently leads the office of Postgraduate Medical Education at the Brigham and Women's Hospital and in this capacity leads several HMS CME courses. He is the author of over 160 original contributions and review articles, as well as author/editor of 11 books in internal medicine and nephrology. Dr. Singh is a Fellow of the Royal College of Physicians in London and has an MBA from Boston University.

Back to top

Wendy St. Peter, PharmD, FASN, FCCP, FNKF

Professor
College of Pharmacy
University of Minnesota
Minneapolis, Minneapolis

Dr. Wendy St. Peter is a Professor in the College of Pharmacy at the University of Minnesota. She received her Doctor of Pharmacy degree from the University of Texas Health Science Center, where she also completed a fellowship in adult medicine. She served as a clinical practitioner at Hennepin County Medical Center in Minneapolis for several years where she provided medication therapy management of dialysis and chronic kidney disease (CKD) patients. Dr. St. Peter’s career has been focused on improving medication management and drug safety in patients with chronic kidney disease (CKD). She conducts pharmacoepidemiology and health economic and outcomes research using Medicare, commercial datasets and electronic health record data. She has served on several national technical expert panels for medication-related safety and quality measurement. She is on the Board of Directors of the Kidney Health Initiative, a private-public partnership with the Food and Drug Administration, American Society of Nephrology, pharmaceutical manufacturers and many other organizations. Dr. St. Peter holds fellowships in the American Society of Nephrology, American College of Clinical Pharmacy and the National Kidney Foundation. Her current research interests include prevention and treatment of CKD symptoms, anemia, mineral and bone disease, and the intersection of heart failure, CKD and acute kidney injury.

Back to top